- Sourcews Report
- File
- HTML
- Size
- 23 Ko
- URL response
- 100%
- Source quality
- 100%
- Sourcews Explorer
Cimzia® studies show significant clinical benefits for mono- and combination therapy in patients with rheumatoid arthritis
20.11.08 - 22:20 ... source : UCB
... EN | FR | NL FAST 4WARD showed monotherapy Cimzia® 400 mg, dosed every four weeks, provided significant and effective clinical benefits compared to placebo RAPID 2 trial showed Cimzia®, together with methotrexate (M ...» Next (HTML)
Similar news
96% | 19.11.08 - 13:34 ... source : AstraZeneca
... ZACTIMA (vandetanib) in combination with chemotherapy agents docetaxel (ZODIAC) and pemetrexed (ZEAL) and as monotherapy (ZEST) in non-small cell lung cancer (NSCLC). Results from the ZODIAC and ZEAL studies showed advantages for vandetanib in combination with chemotherapy, compared to chemotherapy ...
90% | 27.10.08 - 11:34 ... source : Novartis
... ACZ885 dose - treatment needed only every two months to maintain response[1] ACZ885 demonstrated potential to rapidly control Systemic Juvenile Idiopathic Arthritis, the most severe form of arthritis in children[2] Orphan drug status granted to ACZ885 in the EU and ...
90% | 07.10.08 - 21:38 ... source : Novartis
... and potentially faster onset of action[1] Data show NVA237 was well tolerated with good overall safety profile and no clinically relevant cardiovascular findings[2] Chronic obstructive pulmonary disease (COPD) affects 210 million people worldwide[3] - projected to be the third leading ...
88% | 24.09.08 - 06:44 ... source : NPS Pharmaceuticals
... reported that three abstracts summarizing data from the company's Phase 3 studies of GATTEX(TM) (teduglutide) in patients with short bowel syndrome (SBS) were accepted for presentation at the American College of Gastroenterology (ACG) Annual Scientific Meeting and Postgraduate Course in ...
87% | 25.09.08 - 19:02 ... source : Boehringer Ingelheim
... 3 study investigating treatment in an extended time window up to 4.5 hours after symptom onset For Healthcare Media outside the U.S.A., Canada, and Japan 25 September 2008 For medical media, outside the US only Ingelheim, Germany, 25 September 2008 ...
